Compare CVS Health Corp (CVS) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Zillow Group Inc Class C — how do they compare? CVS Health Corp trades at $86.85 (market cap $112.49B), while Zillow Group Inc Class C trades at $29.24 (market cap $6.17B). The key difference: CVS Health Corp is far larger — about 18.2× Zillow Group Inc Class C's market cap, and CVS Health Corp pays a 3.02% dividend while Zillow Group Inc Class C pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Zillow Group Inc Class C for 39 Days on average.
| CVS | Z | |
|---|---|---|
Market Cap | $112.49B | $6.17B |
Volume | 8,467,392 | 2,822,928 |
Sector | Health | Media |
52-Week High | $110.60 | $78.04 |
52-Week Low | $70.08 | $27.13 |
Typical Hold Time | 83 Days | 39 Days |
Enterprise Value | $174.83B | $6.04B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Zillow Group (Z) trades at $27.28, down 1.52% amid bearish technical signals and a challenging housing market. The company shows improving fundamentals with revenue growth from $2.2B in 2024 to $2.6B in 2025 and a return to profitability with net income of $23M. Recent earnings beat expectations in Q1 and Q2 2026, though Q4 2025 missed. Analyst consensus remains mixed with a $60.33 price target representing significant upside potential from current levels.
The stock presents a compelling risk-reward opportunity with strong analyst price targets but faces headwinds from rising mortgage rates and housing market volatility. Zillow's strategic pivot to an integrated transaction platform and AI integration positions it for long-term growth, though near-term performance depends on housing market stabilization and execution of their business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
